Filter
781
Filtered Results: 781
Text search:
Contraceptive
failure
Featured
Recommendations
96
New Publications
290
Language
Document type
No document type
572
Guidelines
111
Studies & Reports
54
Manuals
22
Strategic & Response Plan
7
Training Material
5
Situation Updates
5
Fact sheets
3
Infographics
1
Online Courses
1
Countries / Regions
India
57
South Africa
36
Kenya
34
Ethiopia
34
Nigeria
30
Nepal
27
Uganda
24
Malawi
22
Tanzania
22
Zambia
20
Bangladesh
19
Rwanda
18
Liberia
18
Global
17
Philippines
16
Sierra Leone
15
Namibia
13
Ghana
11
Zimbabwe
11
Myanmar / Burma
11
Lesotho
10
Cambodia
9
Botswana
9
Indonesia
6
Eswatini/ Swaziland
6
Africa
4
Latin America and the Carribbean
4
Western and Central Europe
4
Brazil
4
Ukraine
3
Haiti
3
Asia
3
South Sudan
3
Syria
2
Burkina Faso
2
Guinea
2
Mozambique
2
Venezuela
2
Middle East and North Africa
2
South–East Asia Region
2
East and Southern Africa
2
Eastern Europe
2
Tajikistan
1
Thailand
1
Gambia
1
China
1
Cameroon
1
Bulgaria
1
Armenia
1
USA
1
Lithuania
1
Jordan
1
Congo, Democratic Republic of
1
West and Central Africa
1
Israel
1
Papua New Guinea
1
Sri Lanka
1
Egypt
1
Central African Republic
1
Honduras
1
Libya
1
Bhutan
1
Solomon Islands
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
442
Clinical Guidelines
66
Women & Child Health
57
Public Health
39
Capacity Building
26
Key Resources
8
Pharmacy & Technologies
3
Toolboxes
HIV
102
Pharmacy
35
Mental Health
31
TB
26
COVID-19
14
NCDs
14
Refugee
12
Caregiver
11
Conflict
11
Disability
8
NTDs
8
Planetary Health
7
Global Health Education
7
Ebola
5
AMR
3
Zika
2
Polio
2
Rapid Response
1
Natural Hazards
1
Health Financing Toolbox
1
The new Global AIDS Strategy 2021--2026, End Inequalities, End AIDS, is a bold approach that uses an inequalities lens to close the gaps preventing progress to end AIDS
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong and inclusive health systems have had the best outcomes against HIV. In those countries, people living with and affected by HIV are more likely t...
2021 UNAIDS Global AIDS Update. UNAIDS report shows that people living with HIV face a double jeopardy, HIV and COVID-19, while key populations and children continue to be left behind in access to HIV services
SBMFC Recommendations for PHC during the Pandemic of COVID-19 (edition 4)
This document answers questions and gives recommendations so that the Brazilian PHC can quickly receive the best possible scientific synthesis on the current situation of the pandemic of COVID-19
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
Community health workers (CHWs) enable marginalised communities, often experiencing structural poverty, to access healthcare. Trust, important in all patient–provider relationships, is difficult to build in such
communities, particularly when stigma associated with HIV/AIDS, tuberculosis and now ...
Constraints, Technologies, Policies and Processes
In emergency or humanitarian settings, mobile clinics are used to bring essential lifesaving health care to communities affected by crises. Though there are standard emergency benefit packages for health services during emergencies, there are however no agreed or standard way of running mobile clini...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...
WHO-OHCHR launch new guidance to improve laws addressing human rights abuses in mental health care
Ahead of World Mental Health Day, the World Health Organization (WHO) and the Office of the High Commissioner on Human Rights (OHCHR) are jointly launching a new guidance, entitled "Mental health, h...
This curriculum was designed to train newly recruited health care workers (HCW) in the basic knowledge and skills needed to improve different HIV services within the health facility including identification, linkage, retention and support. In addition to HIV basics, the training has supplementary un...
Diabetes is a major public health problem. The rising incidence of Diabetes Type 2 is related to the effects of urbanization and unhealthy lifestyles. Research studies show that healthy eating and regular physical activity can prevent or delay the onset of Diabetes Type 2, even in high-risk individu...
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome.
This status report shows how far we have come—and how much further we must go—if we hope to meet the global commitments to end AIDS in children. It offers a snapshot of global progress and permits an early assessment of the impact of the Global Alliance’s work.
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
